ZA791941B - Corticoid-17-(alkyl carbonates) and process for their manuufacture - Google Patents

Corticoid-17-(alkyl carbonates) and process for their manuufacture

Info

Publication number
ZA791941B
ZA791941B ZA791941A ZA791941A ZA791941B ZA 791941 B ZA791941 B ZA 791941B ZA 791941 A ZA791941 A ZA 791941A ZA 791941 A ZA791941 A ZA 791941A ZA 791941 B ZA791941 B ZA 791941B
Authority
ZA
South Africa
Prior art keywords
manuufacture
corticoid
alkyl carbonates
carbonates
alkyl
Prior art date
Application number
ZA791941A
Other languages
English (en)
Inventor
W Fritsch
U Stache
H Alpermann
J Sandow
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA791941B publication Critical patent/ZA791941B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA791941A 1978-04-25 1979-04-24 Corticoid-17-(alkyl carbonates) and process for their manuufacture ZA791941B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782817988 DE2817988A1 (de) 1978-04-25 1978-04-25 Corticoid 17-alkylcarbonate und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
ZA791941B true ZA791941B (en) 1980-04-30

Family

ID=6037909

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA791941A ZA791941B (en) 1978-04-25 1979-04-24 Corticoid-17-(alkyl carbonates) and process for their manuufacture

Country Status (19)

Country Link
US (1) US4377575A (no)
EP (1) EP0004975B1 (no)
JP (1) JPS54144357A (no)
AR (1) AR226157A1 (no)
AT (1) AT372094B (no)
AU (1) AU529172B2 (no)
CA (1) CA1130276A (no)
DE (2) DE2817988A1 (no)
DK (1) DK157880C (no)
ES (2) ES479709A1 (no)
FI (1) FI791307A (no)
GR (1) GR72886B (no)
HU (1) HU180788B (no)
IE (1) IE48328B1 (no)
IL (1) IL57114A (no)
NO (1) NO791365L (no)
NZ (1) NZ190256A (no)
PT (1) PT69544A (no)
ZA (1) ZA791941B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
JPS5835199A (ja) * 1981-08-26 1983-03-01 Mitsubishi Chem Ind Ltd モノヨ−ドステロイドおよびその製造法
JPS58103400A (ja) * 1981-12-11 1983-06-20 Ota Seiyaku Kk ６α−メチルプレドニゾロン誘導体
JPS6056997A (ja) * 1983-09-07 1985-04-02 Mitsubishi Chem Ind Ltd 新規な６−酸素化コルチコイド／７α−カ−ボネ−ト誘導体およびその製法
AU558725B2 (en) * 1983-09-07 1987-02-05 Mitsubishi Kasei Corporation Corticoid derivatives
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE4328819A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4333920A1 (de) 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ES2292604T5 (es) * 2000-08-05 2015-06-01 Glaxo Group Limited Éster S-fluorometílico del ácido 6 ,9 -difluoro-17 -[(2-furanilcarbonil)oxi]-11 -hidroxi-16 -metil-3-oxo-androsta-1,4-dien-17 -carbotioico como agente antiinflamatorio
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
CN1302007C (zh) * 2001-04-30 2007-02-28 葛兰素集团有限公司 具有抗炎性的在17.α位上具有环酯基的雄甾烷的17.β.－硫代羧酸酯衍生物
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
MX2010003698A (es) * 2007-10-04 2010-04-21 Astrazeneca Ab Compuestos de [3,2-c]pirazol esteroides con actividad glucocorticoide.
JP2011507836A (ja) * 2007-12-20 2011-03-10 アストラゼネカ・アクチエボラーグ グルココルチコステロイド受容体アゴニストとして作用するステロイド誘導体
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32521A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Combinación para emplear en el tratamiento de enfermedades respiratorias
UY32520A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1253831A (en) * 1968-01-19 1971-11-17 Glaxo Lab Ltd 9alpha,21-DIHALOPREGNANE COMPOUNDS
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
US3558675A (en) * 1969-06-30 1971-01-26 Merck & Co Inc Steroid carbonates and process
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids
YU54476A (en) * 1975-03-31 1982-05-31 Taisho Pharmaceutical Co Ltd Process for obtaining 17-ester 21-halo-pregnane
US4021459A (en) * 1975-08-14 1977-05-03 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy 20-keto-pregnenes
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0004975A3 (en) 1979-11-14
IE790831L (en) 1979-10-25
ATA307479A (de) 1983-01-15
ES479709A1 (es) 1980-08-16
IL57114A0 (en) 1979-07-25
DK157880C (da) 1990-07-30
IL57114A (en) 1983-11-30
US4377575A (en) 1983-03-22
IE48328B1 (en) 1984-12-12
EP0004975B1 (de) 1982-02-17
HU180788B (en) 1983-04-29
NO791365L (no) 1979-10-26
DE2817988A1 (de) 1979-11-08
AT372094B (de) 1983-08-25
AR226157A1 (es) 1982-06-15
JPS54144357A (en) 1979-11-10
NZ190256A (en) 1981-03-16
AU529172B2 (en) 1983-05-26
CA1130276A (en) 1982-08-24
DK168579A (da) 1979-10-26
JPS6252759B2 (no) 1987-11-06
DE2962122D1 (en) 1982-03-25
EP0004975A2 (de) 1979-10-31
PT69544A (de) 1979-05-01
GR72886B (no) 1984-01-02
ES488120A1 (es) 1980-09-16
FI791307A (fi) 1979-10-26
DK157880B (da) 1990-02-26

Similar Documents

Publication Publication Date Title
ZA791941B (en) Corticoid-17-(alkyl carbonates) and process for their manuufacture
GB2020269B (en) Cycloalkylatriazoles and process for obtaining same
JPS5513197A (en) Minute sporule
HU186344B (en) Process for prodiction of solid cianur-chlorid
YU19179A (en) Process for obtaining phosgene
JPS54160754A (en) Method
PH19618A (en) Process for preparing -2-pyrrolidone
JPS5589958A (en) Reelboss for tapeecassette
JPS5558521A (en) Method of moving
GB2038321B (en) Carbonates
JPS54147914A (en) Stabilizing method
JPS54148705A (en) Oxyalkylation process
JPS5517533A (en) Vibrationnproof method
GB2032430B (en) Transesterification process
GB2044147B (en) Cooling method
JPS5517532A (en) Vibrationnproof method
JPS5547860A (en) Germmkilling process
JPS557034A (en) Culture facilities
ZA794245B (en) N-phenethylacetamide compounds and process for preparation thereof
JPS5510453A (en) Slag waterrgranulating method
JPS557309A (en) Waterrproofing method
JPS55109443A (en) Microocapsulizing process
JPS54136733A (en) Oillfence extending method
YU226878A (en) Process for preparing 2-bromo-ergolene and 2-bromo-ergoline compounds
JPS54163107A (en) Method of drawing figure